Aastrom Biosciences Inc., of Ann Arbor, Mich., appointed Alan Wright as senior vice president, administrative and financial operations.
Amnis Corp., of Seattle, hired Ralph Jorgenson as director of intellectual property and grants, Philip Morrissey as principal scientist and Kevin Brintnall as director of finance.
Aradigm Corp., of Hayward, Calif., added Thomas Chesterman as senior vice president and chief financial officer.
Atherotech Inc., of Birmingham, Ala., named Michael Peat vice president of operations.
Atrix Laboratories Inc., of Fort Collins, Colo., promoted David Osborne to vice president of its dermatology division and MingXing Zhou to research fellow of its drug delivery group.
Avanir Pharmaceuticals Inc., of San Diego, added Martin Emanuele as vice president of corporate development.
BioImage A/S, of Soeborg, Denmark, appointed Per Spindler as vice president of preclinical development.
Cell Pathways Inc., of Horsham, Pa., elected Ronald Ahrens to its board.
Chiron Corp., of Emeryville, Calif., named Jack Goldstein president of its blood testing division.
Corgentech Inc., of Palo Alto, Calif., appointed James Huang vice president of marketing and business development.
Curis Inc., of Cambridge, Mass., named Elizabeth Potthoff vice president, general counsel.
DeveloGen AG, of Gottingen, Germany, appointed Klaus Brandau as chairman of its supervisory board.
Dynavax Technologies Corp., of Berkeley, Calif., appointed William Dawson to vice president, finance and operations, and chief financial officer.
Elitra Pharmaceuticals Inc., of San Diego, added Paul Hamelin as president and chief operating officer.
Endovasc Ltd. Inc., of Montgomery, Texas, appointed Kenneth Reilly, Kenneth Beverly, James Davidson and Frank Bagrier to its audit and compensation committees.
EraGen Biosciences Inc., of Madison, Wis., appointed Samraat Raha chief business officer.
Genentech Inc., of South San Francisco, promoted Stephen Juelsgaard to executive vice president, general counsel and secretary.
GenoMed Inc., of St. Louis, added Frank Johnson to its scientific advisory board.
GenVec Inc., of Gaithersburg, Md., appointed David Robinson vice president of marketing and sales.
Human Genome Sciences Inc., of Rockville, Md., added Daniel Gold as senior vice president, process development.
ILEX Oncology Inc., of San Antonio, appointed Mark Mellin senior vice president and chief financial officer.